Jane Huang - CMO, Hematology at BeiGene, Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
CMO, Hematology
Stock Symbol
BGNE on Nasdaq, BEIGF on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jane Huang since 11/5/2023

Holdings reported by Jane Huang for BeiGene, Ltd.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 160K $33.2M $207.72 Dec 14, 2021 Direct
Share Option (Right to Buy) 211K Dec 14, 2021 Direct Ordinary Shares
American Depositary Shares 0 $180.50 Dec 14, 2021 Direct

Transactions reported by Jane Huang for BeiGene, Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.